Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

181 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms

NCT01309789

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Tandem Auto-Allo Transplant for Lymphoma

NCT01181271

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse, Large B-Cell, Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

AMG 319 Lymphoid Malignancy FIH

NCT01300026

Conditions
Cancer, Chronic Disease, Chronic Lymphocytic Leukemia, +33 more
Locations
  • Research Site Hackensack, New Jersey, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Salt Lake City, Utah, United States
View Trial Details
Completed

A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)

NCT00611208

Conditions
Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
Locations
  • Yale University School Of Medicine Recruiting New Haven, Connecticut, United States
  • James Graham Brown Cancer Center Louisville, Kentucky, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01421667

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists Oxnard, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 34 locations
View Trial Details
Completed

Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma

NCT00798096

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Stanford, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Boston, Massachusetts, United States
View Trial Details

Related conditions